What's new? Log in Free sign up

Filing search / Current reports / Phaserx, Inc.

Search information

Current reports

Filing Types

Phaserx, Inc.

Companies

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

31 filings

Newest first

PZRX Phaserx, Inc.

PZRX Phaserx, Inc.

Entry into a Material Definitive Agreement

PZRX Phaserx, Inc.

Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

PZRX Phaserx, Inc.

PZRX Phaserx, Inc.

2p3u1q8 briuvyc

PhaseRx Receives Decision from the Nasdaq Hearings Panel for Continued Listing of Shares

Bankruptcy or Receivership

PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL from European Medicines Agency

PhaseRx Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Regulation FD Disclosure

kbt2vh25m4vn5l1bxu86

PhaseRx Receives Delisting Notice from Nasdaq and Evaluates Listing Options

PhaseRx Announces Corporate Restructuring and Review of Strategic Alternatives

nn9qi4y li8dguh

Departure of Directors or Certain Officers

PhaseRx Receives Orphan Drug Designation from FDA for PRX-ASL for the Treatment of Argininosuccinate Lyase Deficiency

1hutdjqnqoew mxcrz4e

Departure of Directors or Certain Officers

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

PhaseRx Reports Second Quarter 2017 Financial Results and Provides Corporate Update

Submission of Matters to a Vote of Security Holders

rpd3azcdp5ts rkawbq

PhaseRx Reports First Quarter 2017 Financial Results and Provides Corporate Update

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.